Evidence map›Paper›PMID 39620067›Full record

ReviewJACC. Advances2024

Tobacco Use, Electronic Nicotine Delivery Systems, and Vulnerable Populations: Current Landscape and Opportunities for Improvement.

Mohammed Abozenah, Noreen T Nazir, Nishtha Sareen, Eric Brandt, Quinn R Pack, Uzoma Ibebuogu, Mrinali Shetty, Kavisha Singh, Eric C Stecker, Eugene Yang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammed AbozenahDepartment of Cardiovascular Medicine, University of Massachusetts Medical School - Baystate Medical Center, Springfield, Massachusetts, USA.
Noreen T NazirDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Nishtha SareenAscension St Mary's, Central Michigan University, Saginaw, Michigan, USA.
Eric BrandtInstitute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.
Quinn R PackDepartment of Cardiovascular Medicine, University of Massachusetts Medical School - Baystate Medical Center, Springfield, Massachusetts, USA.
Uzoma IbebuoguDepartment of Medicine, University of Tennessee Health Science Campus, Knoxville, Tennessee, USA.
Mrinali ShettyDepartment of Medicine, Columbia University, New York, New York, USA.
Kavisha SinghProvidence Spokane Cardiology, Spokane, Washington, USA.
Eric C SteckerKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA.
Eugene YangDivision of Cardiology, University of Washington School of Medicine, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tobacco epidemic has claimed countless lives, caused significant morbidity, and cost billions of dollars in direct costs and lost productivity. Despite its acute vascular effects, nicotine alone has not been definitively linked to cardiovascular events. Rather, additives found in cigarettes and other tobacco products likely play a bigger role in tobacco's link to cardiovascular events. The emergence of electronic nicotine delivery systems introduces a new challenge, particularly among certain groups. Understanding the groups vulnerable to tobacco product use, identifying factors that influence this vulnerability, and examining different approaches to mitigating these factors is imperative to curbing the detrimental effects of the tobacco epidemic. Ameliorating screening and treatment efforts will require collaborative efforts that involve clinicians, health care systems, local and regional communities, government agencies, policymakers, and medical societies.

Indexed as

preventionscreeningsmokingtobaccovulnerable populations

Identifiers

PMID39620067
PMCPMC11607422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.